Market revenue in 2023 | USD 67.7 million |
Market revenue in 2030 | USD 128.5 million |
Growth rate | 9.6% (CAGR from 2023 to 2030) |
Largest segment | Clinical diagnostics |
Fastest growing segment | Cannabis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Diagnostics, Pharmaceuticals, Microbiology, Cannabis |
Key market players worldwide | LGC Group, Bio-Rad Laboratories Inc, Randox, Merck KGaA, Randox Biosciences, QACS International, Weqas, BIPEA, NSI Lab Solutions, Absolute Standards, Instand |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory proficiency testing market will help companies and investors design strategic landscapes.
Clinical diagnostics was the largest segment with a revenue share of 33.09% in 2023. Horizon Databook has segmented the China laboratory proficiency testing market based on clinical diagnostics, pharmaceuticals, microbiology, cannabis covering the revenue growth of each sub-segment from 2018 to 2030.
According to a study published by the UK’s NHS, healthcare expenditure in China is projected to reach USD 25.2 billion by 2027, as the country has the largest population in the world. In addition, the prevalence of chronic conditions, such as Alzheimer’s disease, COPD, breast cancer, and prostate cancer, is increasing in China.
These diseases are propelling the demand for improved, technologically advanced, and accurate diagnostic laboratories that can help in the management of these conditions, increasing the need for reliable accredited laboratories.
The country’s biopharmaceutical sector is growing owing to high investments in R&D by the Chinese government. For instance, over USD 291 billion has been invested in biotechnology R&D by the Chinese government over the past few years.
Horizon Databook provides a detailed overview of country-level data and insights on the China laboratory proficiency testing market , including forecasts for subscribers. This country databook contains high-level insights into China laboratory proficiency testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account